Thursday, February 26, 2015

#Pharmacyclics which bought #Cancer drug Imbruvica for just $6.6 million will planning to sell itself for $18 billion as companies like Johnson & Johnson and Novartis have shown interest according to #Bloomberg

Pharmacyclics which bought Cancer drug Imbruvica for just $6.6 million will planning to sell itself for $18 billion as companies like Johnson & Johnson and Novartis have shown interest according to Bloomberg
http://www.wikio.co.uk